Fitterfly has raised $12 million in series A funding.


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Fitterfly, a Mumbai-based health tech business, would utilize the funding to strengthen its technological stack and branding, as well as expand the scope of its diabetes management digital therapies program.

Fitterfly, a health tech startup, raised $12 million in a Series A round led by Amazon Smbhav Venture Fund and Fireside Ventures.

This follows a $3.1 million pre-Series A financing launched in April of last year. The current round brings the startup's total funding to $16.6 million to date. 

The round was also attended by 9 Unicorns, Venture Catalysts, Nihar Parikh of 4point0 Health Ventures, and Sriram Natarajan of Molbio.

The funding will be used by the Mumbai-based business to strengthen its technological stack and branding, as well as expand the scope of its diabetes management digital therapies program, Diabefly.

"This funding will help us strengthen our research, launch new verticals in the heart health space, and grow our customer base by reaching out to people living with diabetes as well as the universe of doctors and organizations in the field of chronic disease management," said Dr. Arbinder Singal, Fitterfly's CEO and Co-Founder.

"We want to provide our clinically proven diabetes and weight control approach to the individuals who need it the most," he continued.

Fitterfly, created in 2016 by Dr. Arbinder Singal and Shailesh Gupta, provides individualized digital treatment programs to provide health results for diabetes, pregnancy, PCOS, and obesity.

According to the business, it has handled over 20,000 patients with a 360-degree care strategy and professionally recommended therapy by over 200 doctors throughout India.

"I've known Arbinder for over a decade, and his expertise as a doctor and serial entrepreneur is tremendously valuable for establishing an influential global firm," said Kanwaljit Singh, Fireside Ventures' Founder and Managing Partner.

This is Amazon Smbhav Venture Fund's first investment in Indian health tech. Amazon has created a $250 million small company fund.

 

Tags : #fitterfly #aseriesfunding #AmazonSmbhavVentureFunds #9Unicorns #Venture #4point0Health #Fundingalert #funding

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026